First Minimally Invasive Procedure for Lumbar Disc Repair
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Mesoblast
- Response to ASXPrice Query
- Price Query
- Positive Results in Phase 2 Lumbar Spinal Fusion Trial
- MSB Provides Corporate Strategy For Neurologic Product
- Mesoblast Corporate Overview - CEO Message to AGM
Later from Mesoblast
- Appendix 4C - Strong Cash Position
- Appendix 4D and Half Year Financial Report to 31 Dec 2010
- Cardiac Events, Mortality and Hospitalization Reduced
- FDA Clears Phase 2 Trial to Treat Degenerative Disc Disease
- Key Product Franchises Featured at Nomura Asia Equity Forum
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast